Preoperative anxiolytic effect of melatonin and clonidine on postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy: a double-blind, randomized, placebo-controlled study.

Anesthesia Service and Perioperative Medicine, Hospital de CLíNICAS DE Porto Alegre/Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
The journal of pain: official journal of the American Pain Society (Impact Factor: 4.22). 12/2008; 10(1):100-8. DOI: 10.1016/j.jpain.2008.08.007
Source: PubMed

ABSTRACT Recent evidence has demonstrated analgesic, anti-inflammatory, and anxiolytic properties of melatonin. Taking into account that higher anxiety makes the control of postoperative pain more difficult, one can hypothesize that melatonin anxiolytic and analgesic effects improve the control of postoperative pain. Thus, we conducted a randomized, double-blind, placebo-controlled study with 59 patients undergoing abdominal hysterectomy to test the hypothesis that melatonin is as effective as clonidine and that both are more effective than placebo in reducing postoperative pain. Additionally, we compared their anxiolytic effects on postoperative pain. Patients were randomly assigned to receive oral melatonin (5 mg) (n = 20), clonidine (100 microg) (n = 19), or placebo (n = 20) orally. In addition to primary outcomes of pain intensity and analgesic consumption, secondary outcome measures included postoperative state anxiety. In anxious patients 6 hours after surgery, the number of patients needed to be to prevent moderate to intense pain during the first 24 hours after surgery was 1.52 (95% CI, 1.14 to 6.02) and 1.64 (95% CI, 1.29 to 5.93), respectively, in the melatonin and clonidine groups compared with placebo. Also, the anxiolytic effect of melatonin and clonidine resulted in reduced postoperative morphine consumption by more than 30%. However, in the mildly anxious, it was not observed the treatment effect on pain. PERSPECTIVES: The preoperative anxiolysis with melatonin or clonidine reduced postoperative pain and morphine consumption in patients undergoing abdominal hysterectomy. The effects these 2 drugs were equivalent and greater than with placebo.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Exercise-induced hypoalgesia (EIH) typically reported during and/or following exercise, but less is known the mechanisms responsible for EIH. Previous reports suggest that melatonin plays a role in pain modulation. In this study, we investigated the role of melatonin on pain threshold at rest, and following exercise in both sedentary and exercise trained rats under light-induced functional pinealectomy. Male wistar rats were assigned to one of four groups: sedentary control (C), sedentary pinealectomized (Px), exercise trained (T), and trained under pinealectomy (T-Px) groups. Exercise trained groups were subjected to eight weeks of motor-driven treadmill exercise. C and T groups exposed to normal light/dark cycle (12:12-h light/dark cycle) and Px and T-Px rats exposed to continuous light for eight weeks. Hot-plate test was repeated before and after melatonin injection and paw withdrawal latencies were recorded as pain threshold. Acute exercise resulted increased pain threshold in all groups. Animals in T group had significantly highest pain thresholds compared with other groups, and pinealectomy resulted decreased pain threshold in trained animals both at rest, and following exercise. Pain threshold in T-Px group was found to be increased after melatonin administration. Our findings support the hypothesis that melatonin plays a role on hypoalgesic response in exercise-trained rats.
    Biological Rhythm Research 11/2014; 45(6). DOI:10.1080/09291016.2014.923619 · 1.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Transcranial direct current stimulation (tDCS) and melatonin can effectively treat pain. Given their potentially complementary mechanisms of action, their combination could have a synergistic effect. Thus, we tested the hypothesis that compared to the control condition and melatonin alone, tDCS combined with melatonin would have a greater effect on pain modulatory effect, as assessed by quantitative sensory testing (QST) and by the pain level during the Conditioned Pain Modulation (CPM)-task. Furthermore, the combined treatment would have a greater cortical excitability effect as indicated by the transcranial magnetic stimulation (TMS) and on the serum BDNF level. Healthy males (n = 20), (aged 18-40 years), in a blinded, placebo-controlled, crossover, clinical trial, were randomized into three groups: sublingual melatonin (0.25 mg/kg) + a-tDCS, melatonin (0.25 mg/kg) + sham-(s)-tDCS, or sublingual placebo+sham-(s)-tDCS. Anodal stimulation (2 mA, 20 min) was applied over the primary motor cortex. There was a significant difference in the heat pain threshold (°C) for melatonin+a-tDCS vs. placebo+s-tDCS (mean difference: 4.86, 95% confidence interval [CI]: 0.9 to 8.63) and melatonin+s-tDCS vs. placebo+s-tDCS (mean: 5.16, 95% CI: 0.84 to 8.36). There was no difference between melatonin+s-tDCS and melatonin+a-tDCS (mean difference: 0.29, 95% CI: -3.72 to 4.23). The mean change from the baseline on amplitude of motor evocate potential (MEP) was significantly higher in the melatonin+a-tDCS (-19.96% ± 5.2) compared with melatonin+s-tDCS group (-1.36% ± 5.35) and with placebo+s-tDCS group (3.61% ± 10.48), respectively (p < 0.05 for both comparisons). While melatonin alone or combined with a-tDCS did not significantly affect CPM task result, and serum BDNF level. The melatonin effectively reduced pain; however, its association with a-tDCS did not present an additional modulatory effect on acute induced pain.
    Frontiers in Behavioral Neuroscience 01/2015; 9:77. DOI:10.3389/fnbeh.2015.00077 · 4.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Central disinhibition is a mechanism involved in the physiopathology of fibromyalgia. Melatonin can improve sleep quality, pain and pain threshold. We hypothesized that treatment with melatonin alone or in combination with amitriptyline would be superior to amitriptyline alone in modifying the endogenous pain-modulating system (PMS) as quantified by conditional pain modulation (CPM), and this change in CPM could be associated with serum brain-derived neurotrophic factor (BDNF). We also tested whether melatonin improves the clinical symptoms of pain, pain threshold and sleep quality.
    07/2014; 15(1):40. DOI:10.1186/2050-6511-15-40


Available from
Jun 24, 2014